Clinical Trial

Long-term Follow-up of Patients With Alcoholic Liver Cirrhosis Who Had Administered Cellgram-LC in PMC-P-07 Study

Recruiting
View on ClinicalTrials.gov →
Summary
This Long-term follow-up is designed to evaluate the safety of patient with Alcoholic Liver Cirrhosis who had administered Cellgram-LC in PMC-P-07 study.
Protocol Amendment History 2 amendments
This ClinicalTrials.gov record has been amended 2 times since 2021-10-13; most recent amendment 2024-03-20.
Trial Details
NCT Number NCT05093881
Lead Sponsor Pharmicell Co., Ltd.
Conditions Alcoholic Cirrhosis
Enrollment 100 participants
Start Date 2021-08-24
Primary Completion 2026-08-24 (estimated)
Study Completion 2028-03-31 (estimated)
Updated on ClinicalTrials.gov 2024-03-21